Results
983
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
983 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2083 | ر.س62.20 | -2.7% | -21.1% | ر.س15.8b | ر.س80.75 | PE33.7x | E28.4% | 3.5% | Utilities | ||
RAY B | SEK 139.00 | -0.6% | 95.8% | SEK 4.8b | SEK 195.00 | PE47.3x | E33.6% | 0.5% | Healthcare | ||
VTSC | €56.00 | -5.6% | -26.7% | €2.2b | €74.72 | PB0.8x | E62.7% | 0.4% | Automobiles | ||
NAPA | US$7.22 | -4.7% | -43.6% | US$1.1b | US$9.63 | PE17x | E24.9% | n/a | Food, Beverage & Tobacco | ||
PAAS | CA$29.61 | -5.9% | 43.8% | CA$11.4b | CA$35.55 | PS3.1x | E76.4% | 1.9% | Materials | ||
3738 | HK$1.15 | -7.3% | -58.3% | HK$2.6b | HK$6.49 | PS1.3x | E66.6% | n/a | Software | ||
SINCH | SEK 28.51 | 8.1% | 2.9% | SEK 24.1b | SEK 37.39 | PE122.7x | E50.2% | n/a | Software | ||
RAD | €1.10 | -0.9% | -12.7% | €9.7m | €2.15 | PE20.9x | E40.3% | n/a | Consumer Durables | ||
3436 | JP¥2,341.00 | -9.7% | 13.3% | JP¥818.6b | JP¥2,750.88 | PE26.2x | E24.3% | 2.3% | Semiconductors | ||
1860 | HK$1.85 | -8.0% | -51.7% | HK$2.8b | HK$5.50 | PE13.8x | E20.3% | n/a | Media | ||
ATG | UK£4.85 | 2.2% | -32.6% | UK£589.8m | UK£7.16 | PE54.7x | E34.2% | n/a | Consumer Services | ||
VOLO | SEK 120.20 | 6.4% | 21.2% | SEK 9.5b | SEK 138.00 | PE43.6x | E35.9% | 1.6% | Capital Goods | ||
RED | AU$0.38 | -7.4% | 102.7% | AU$2.6b | n/a | PE52.3x | E47.5% | n/a | Materials | ||
300143 | CN¥7.37 | -1.3% | -32.3% | CN¥4.7b | CN¥10.12 | PE53.7x | E28.5% | 0% | Healthcare | ||
VAC | US$85.37 | -3.3% | -32.6% | US$2.9b | US$114.33 | PE14x | E22.9% | 3.6% | Consumer Services | ||
NUS | €0.95 | -4.2% | -22.0% | €18.9m | €3.17 | PE8.6x | E28.0% | n/a | Capital Goods | ||
1211 | HK$235.80 | -3.0% | -13.1% | HK$756.0b | HK$295.58 | PE20.9x | E15.3% | 1.4% | Automobiles | ||
BEG | UK£1.00 | -4.2% | -24.5% | UK£156.2m | UK£1.71 | PE107.6x | E53.7% | 4.0% | Commercial Services | ||
2755 | CN¥9.53 | -6.5% | 13.7% | CN¥8.8b | CN¥13.00 | PS5.7x | E90.7% | 0% | Pharmaceuticals & Biotech | ||
ARE | CA$14.80 | 2.5% | 41.8% | CA$886.1m | CA$18.36 | PE70.5x | E125.1% | 5.1% | Capital Goods | ||
MXI | AU$2.00 | -3.8% | -27.0% | AU$110.3m | AU$2.74 | PE17.2x | E28.9% | 2.9% | Capital Goods | ||
HNL | €17.60 | 1.1% | -21.1% | €106.7m | €25.20 | PS1.1x | E121.4% | n/a | Capital Goods | ||
GTII | CA$15.30 | -4.2% | 74.1% | CA$3.6b | CA$28.11 | PE44.9x | E27.9% | n/a | Pharmaceuticals & Biotech | ||
4194 | JP¥7,650.00 | -1.9% | 0.1% | JP¥297.6b | JP¥9,266.67 | PE21.7x | E11.2% | n/a | Commercial Services |